Volume 145, Issue 2, Pages 348-356.e2 (August 2013) Associations Between Colorectal Cancer Molecular Markers and Pathways With Clinicopathologic Features in Older Women N.Jewel Samadder, Robert A. Vierkant, Lori S. Tillmans, Alice H. Wang, Daniel J. Weisenberger, Peter W. Laird, Charles F. Lynch, Kristin E. Anderson, Amy J. French, Robert W. Haile, John D. Potter, Susan L. Slager, Thomas C. Smyrk, Stephen N. Thibodeau, James R. Cerhan, Paul J. Limburg Gastroenterology Volume 145, Issue 2, Pages 348-356.e2 (August 2013) DOI: 10.1053/j.gastro.2013.05.001 Copyright © 2013 AGA Institute Terms and Conditions
Figure 1 Kaplan–Meier curves. All-cause mortality by independent marker status. (A) MSI; (B) CIMP; (C) BRAF mutation; and (D) KRAS mutation. Gastroenterology 2013 145, 348-356.e2DOI: (10.1053/j.gastro.2013.05.001) Copyright © 2013 AGA Institute Terms and Conditions
Figure 2 Kaplan–Meier curves. CRC mortality by independent marker status. (A) MSI; (B) CIMP; (C) BRAF mutation; and (D) KRAS mutation. Gastroenterology 2013 145, 348-356.e2DOI: (10.1053/j.gastro.2013.05.001) Copyright © 2013 AGA Institute Terms and Conditions
Figure 3 Kaplan–Meier curves. All-cause and CRC mortality by integrated pathway assignments. (A) All-cause mortality by traditional, alternate, serrated, or other (unassigned) pathways. (B) CRC mortality by traditional, alternate, serrated, or other (unassigned) pathways. (C) All-cause mortality in pathway unassigned cases (cluster A, cluster B, or other). (D) CRC mortality in pathway unassigned cases (cluster A, cluster B, or other). Gastroenterology 2013 145, 348-356.e2DOI: (10.1053/j.gastro.2013.05.001) Copyright © 2013 AGA Institute Terms and Conditions